Disruption of IRS-2 gene results in diabetes 2 symptoms: peripheral insulin resistance and insulin secretion deficiency

被引：0
|
作者：
Joshi, RL
Bucchini, D
Jami, J
De Meyts, P
机构：
来源：
M S-MEDECINE SCIENCES | 1998年 / 14卷 / 05期
关键词：
D O I：
10.4267/10608/1108
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：644 / 646
页数：3
相关论文
共 50 条
  • [41] Insulin resistance through down regulation of insulin receptor substrate (IRS)-1 and IRS-2 in patients with chronic hepatitis C virus infection.
    Kawaguchi, T
    Harada, M
    Yoshida, T
    Taniguchi, E
    Kumemura, H
    Hanada, S
    Baba, S
    Maeyama, M
    Koga, H
    Kumashiro, R
    Ueno, T
    Tanikawa, K
    Sata, M
    HEPATOLOGY, 2003, 38 (04) : 456A - 457A
  • [42] Combined defects in IRS-1 and IRS-2 genes me associated with insulin resistance in polycystic ovary syndrome
    El Mkadem, SA
    Lautier, C
    Macari, F
    Mechaly, I
    Renard, E
    Cros, G
    Bringer, J
    White, MF
    Grigorescu, F
    DIABETES, 1999, 48 : A436 - A436
  • [43] Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors - Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2
    He, WM
    Craparo, A
    Zhu, YY
    ONeill, TJ
    Wang, LM
    Pierce, JH
    Gustafson, TA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (20) : 11641 - 11645
  • [44] Adiponectin enhances insulin signaling by increasing IRS-2 protein in liver
    Awazawa, Motoharu
    Ueki, Kohjiro
    Kaneko, Kazuma
    Kubota, Naoto
    Yamauchi, Toshimasa
    Kadowaki, Takashi
    DIABETES, 2007, 56 : A390 - A390
  • [45] TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes
    Nakagawa, Y
    Shimano, H
    Yoshikawa, T
    Ide, T
    Tamura, M
    Furusawa, M
    Yamamoto, T
    Inoue, N
    Matsuzaka, T
    Takahashi, A
    Hasty, AH
    Suzuki, H
    Sone, H
    Toyoshima, H
    Yahagi, N
    Yamada, N
    NATURE MEDICINE, 2006, 12 (01) : 107 - 113
  • [46] TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes
    Yoshimi Nakagawa
    Hitoshi Shimano
    Tomohiro Yoshikawa
    Tomohiro Ide
    Mariko Tamura
    Mika Furusawa
    Takashi Yamamoto
    Noriyuki Inoue
    Takashi Matsuzaka
    Akimitsu Takahashi
    Alyssa H Hasty
    Hiroaki Suzuki
    Hirohito Sone
    Hideo Toyoshima
    Naoya Yahagi
    Nobuhiro Yamada
    Nature Medicine, 2006, 12 : 107 - 113
  • [47] Characterization of insulin secretion and resistance in type 2 diabetes of adolescents
    Druet, C
    Tubiana-Rufi, N
    Chevenne, D
    Rigal, O
    Polak, M
    Levy-Marchal, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) : 401 - 404
  • [48] The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2
    Hanke, Stefan
    Mann, Matthias
    MOLECULAR & CELLULAR PROTEOMICS, 2009, 8 (03) : 519 - 534
  • [49] Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action
    Rabiee, Atefeh
    Krueger, Marcus
    Ardenkjaer-Larsen, Jacob
    Kahn, C. Ronald
    Emanuelli, Brice
    CELLULAR SIGNALLING, 2018, 47 : 1 - 15
  • [50] Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion
    Groop, L
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 3 - 13
12345